Summary
Respiratory tract infection (RTI) poses a serious threat to the health of patients in all age groups. Low birthweight, poor nutritional status, smoking, overcrowding and breathing polluted air may predispose one to the development of this disorder. While viruses are the main pathogens, different bacteria are involved in upper and lower RTI When identifying the offending bacterial pathogen, one must take into account local antimicrobial resistance patterns. Selection of an appropriate antibiotic requires consideration of pharmacokinetic and pharmacodynamic properties and antibacterial activity to ensure the use of drugs that will aid patient compliance with the prescribed regimen. Additional factors in the decision of which antimicrobial to use include in vitro susceptibility, proven efficacy in controlled clinical trials, low cost, safety and good oral absorption. In this regard, macrolides, particularly the newer agents such as roxithromycin, may be considered effective therapy in RTI.
Similar content being viewed by others
References
Anon. Indoor air and human health. Lancet 1: 1419-1420, 1986
Bosso JA. Bacterial resistance to antibiotics: mechanisms and prevalence in hospitals and nursing homes. DICP: Annals of Pharmacotherapy 23: 556–561, 1989
Arredondo GJL, Espinoza LE, Zepeda H. Infecciones por Haemophilus influenzae. Problema actual en pediatría. Boletín Médico del Hospital Infantil de México 44: 777–785, 1986
Bryan CS. Strategies to improve antibiotic use. Infectious Disease Clinics of North America 3: 723–734, 1989
Cherry JD. Pharyngitis (pharyngitis, tonsillitis, tonsillo-pharyngitis). In Feigin RD, Cherry JD (Eds) Text of paediatric infectious diseases, 2nd ed., pp. 179–188, WB Saunders Co., Philadelphia, 1987
Claesson BA, Trollfors B, Brolin I, Granström M, Henrichsen J, et al. Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatric Infectious Diseases Journal 8: 856–862, 1989
Cole P. Host-microbe relationships in chronic respiratory infection. Respiration 55(Suppl. 1): 5–8, 1989
Colley JRT, Miller DL. Acute respiratory infections. Chest 96(Suppl. 3): 355S–360S, 1989
Douglas JWB, Waller RE. Air pollution and respiratory infection in children. British Journal of Preventative Society Medicine 20: 1–8, 1966
Finch R. Treatment of respiratory tract infections with cephalosporin antibiotics. Drugs 34(Suppl. 2): 180–204, 1987
Gardner G, Frank AL, Taber LH. Effects of social and family factors on viral respiratory infection and illness in the first year of life. Journal of Epidemiology and Community Health 38: 42–48, 1984
John JT, Cherian T, Steinhoff MC, et al. Etiology of acute respiratory infections in children in tropical Southern India. Reviews of Infectious Diseases 13(Suppl. 6): 463–469, 1991
Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrobial Agents and Chemotherapy 34: 2075–2080, 1990
Kendall PA, Leeder SR. Environmental factors relating to acute respiratory infections in childhood: possibilities for prevention. In Douglas R, Kirby-Eaton E (Eds) Acute respiratory infections in children. Proceedings of an International Workshop, University of Adelaide, pp. 72–77, 1985
Kirst HA, Sides GD. New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy. Antimicrobial Agents and Chemotherapy 33: 1419–1422, 1989
Kunin CM, Johansen KS, Worning AM, Daschner FD. Report of a symposium on use and abuse of antibiotics worldwide. Reviews of Infectious Disease 12: 12–19, 1990
Mackowiak PA, Martin RM, Smith JW. The role of bacterial interference in the increased prevalence of oropharyngeal Gram-negative bacilli among alcoholics and diabetics. American Review of Respiratory Diseases 120: 589–593, 1979
Modai J. The clinical use of macrolides. Journal of Antimicrobial Chemotherapy 22(Suppl. B): 145–153, 1988
Muder RR, Yu VL, Pang GD. Community-acquired legionnaires disease. Seminars in Respiratory Infection 4: 32–39, 1989
Neu HC. Overview of mechanisms of bacterial resistance. Diagnostic Microbiology and Infectious Disease 12(Suppl. 4): 109S–116S, 1989a
Neu HC. Antimicrobial agents: the old and the new. American Journal of Infection Control 17: 276–285, 1989b
Nightingale CH. Interaction of microbiology and pharmacokinetics in the selection of appropriate antibiotic therapy. DICP: Annals of Pharmacotherapy 23(Suppl. 7/8): S16–S20, 1989
Palacios GC, Solórzano F, Arredondo JL. Neonatal pneumonia. Diagnóstico y Terapéutica en Infectología 10: 287–295, 1990
Peixoto S. Bacterial resistance in South America. International Journal of Gynaecology and Obstetrics 2 (Suppl.): 3–5, 47–48, 1989
Periti P, Mazzei T, Mini E, Novelli A. Clinical pharmacokinetics of the macrolide antibiotics. Effects of age and various pathophysiological states (part II). Clinical Pharmacokinetics 16: 261–282, 1989
Sande MA, Mandell GL. Antimicrobial agents: general considerations. In Gilman AG, et al. (Eds) The pharmacological basis of therapeutics, 6th ed., pp. 1080–1105, Macmillan Publishing Co., New York, 1980
Selwyn BJ. The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Reviews of Infectious Diseases 12(Suppl. 8): 5870–5888, 1990
Solórzano F, Arredondo JL, Ortiz FJ, Diaz RD, Cazares M, et al. Streptococcus del grupo B en la etiología de la infeccion neonatal. Boletín Médico del Hospital Infantil de México 47: 146–152, 1990
Tager IB. Health effects of ‘passive smoking’ in children. Chest 96: 1161–1164, 1989
Tremblay D, Jaeger H, Fourtillan B, Manuel C. Pharmacokinetics of three single doses (150, 300, 450mg) of roxithromycin in young volunteers. British Journal of Clinical Practice 42(Suppl. 55): 49–50, 1988
Tupasi TE. Nutrition and acute respiratory infection. In Douglas R, Kirby-Eaton E (Eds). Acute respiratory infections in children. Proceedings of an International Workshop, University of Adelaide, pp. 68–71, 1985
Valcke Y, Pauwels R, Van Der Straeten M. Pharmacokinetics of antibiotics in the lungs. European Respiratory Journal 3: 715–722, 1990
Valenti WM. Trudell RG, Bentley DW. Factors predisposing to oropharyngeal colonization with Gram-negative bacilli in the aged. New England Journal of Medicine 298: 1108–1111, 1978
Wallace RJ, Steele LC, Brooks DL, et al. Ampicillin, tetracycline and chloramphenicol resistant Haemophilus influenzae in adults with chronic lung disease. American Review of Respiratory Disease 132: 693–699, 1988
World Health Organization. Programme for control of ARI. Biomedicai and epidemiological research priorities of the global scientific working group. WHO/AR/88.1 Geneva. World Health Organization: 1–10, 1988
Young RA, Gonzalez JP, Sorkin EM. Roxithromycin: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 37: 8–41, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arredondo-García, JL. Therapeutic Concepts in Drug Prescribing for Respiratory Tract Infection. Drug Invest 3 (Suppl 3), 33–37 (1991). https://doi.org/10.1007/BF03258333
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03258333